CHRS
Coherus BioSciences Inc
Price:  
0.80 
USD
Volume:  
1,270,809.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS DCF Valuation - Growth Exit 5Y

51.2%
Upside

What is the DCF valuation of CHRS??

The Discounted Cash Flow (DCF) valuation of Coherus BioSciences Inc (CHRS) is 1.20 USD. With the latest stock price at 0.80 USD, the upside of Coherus BioSciences Inc based on DCF is 51.2%.

Is CHRS a buy or a sell?

Based on the latest price of 0.80 USD and our DCF valuation, Coherus BioSciences Inc (CHRS) is a buy. buying CHRS stocks now will result in a potential gain of 51.2%.

Range Selected
WACC / Discount Rate 5.7% - 6.5% 6.1%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price 0.36 - 5.67 1.20
Upside -55.2% - 613.4% 51.2%
0.80 USD
Stock Price
1.20 USD
Fair Price